Showing results (41-50 of 586) with videos related to
Sort By:
Pageof 59
Health Affairs (Project Hope)|September 13, 2006
How changes in drug-safety regulations affect the way drug and biotech companies invest in innovationShelby D Reed, Robert M Califf, Kevin A SchulmanAmerican Heart Journal|December 9, 2008
Considerations of net present value in policy making regarding diagnostic and therapeutic technologiesRobert M Califf, Emma B Rasiel, Kevin A SchulmanScience (New York, N.Y.)|April 9, 2026
Diagnostics investments and disease burdenKathryn A Phillips, Danea M Horn, Robert M CaliffThe American Journal of Medicine|May 1, 2007
Performance measures have a major effect on cardiovascular outcomes: a reviewRajendra H Mehta, Eric D Peterson, Robert M CaliffNPJ Digital Medicine|July 16, 2019
The digital transformation of medicine can revitalize the patient-clinician relationshipHaider J Warraich, Robert M Califf, Harlan M KrumholzHealth Affairs Scholar|May 12, 2025
Beyond regulation: a conversation with Dr. Robert Califf on the challenges facing healthcare and innovating community-based solutions: How can the United States harness technological innovation to transform its healthcare system to improve population health outcomes?Robert M Califf, Danea M Horn, Kathryn A PhillipsMedical Care|January 8, 2026
How PCORnet® Could Advance Postmarket Evidence GenerationAli B Abbasi, Lesley H Curtis, Robert M CaliffAmerican Journal of Hematology|August 4, 2009
Decitabine combined with fractionated gemtuzumab ozogamicin therapy in patients with relapsed or refractory acute myeloid leukemiaSaeeda Chowdhury, Stuart Seropian, Peter W MarksAmerican Heart Journal|April 8, 2003
Anticoagulation in acute cardiac care in patients with chronic kidney diseaseDonal Reddan, Lynda A Szczech, Susan O'Shea, et al.Circulation|January 25, 2019
Call to Action: Urgent Challenges in Cardiovascular Disease: A Presidential Advisory From the American Heart AssociationMark McClellan, Nancy Brown, Robert M Califf, et al.Pageof 59